Viewing Study NCT06248866



Ignite Creation Date: 2024-05-06 @ 8:04 PM
Last Modification Date: 2024-10-26 @ 3:20 PM
Study NCT ID: NCT06248866
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-02-08
First Post: 2024-01-31

Brief Title: Effect Of Extracorporeal Shock Wave Therapy On Ultrasonography Changes In Patients With Palmar Fibromatosis A Randomized Controlled Trial
Sponsor: Cairo University
Organization: Cairo University

Study Overview

Official Title: Effect Of Extracorporeal Shock Wave Therapy On Ultrasonography Changes In Patients With Palmar Fibromatosis A Randomized Controlled Trial
Status: NOT_YET_RECRUITING
Status Verified Date: 2024-01
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: ESWT
Brief Summary: this study will be conducted to investigate the effect of extracorporeal shock wave therapy on ultrasonography chnges In patients with palmar fibromatosis
Detailed Description: Palmar fibromatosis also known as Dupuytrens contracture is a condition that affects the hand and fingers It is characterized by the thickening and tightening of the fascia a layer of connective tissue beneath the skin of the palm This thickening and tightening can lead to the formation of nodules or cords that restrict the movement of the affected fingers The treatment options for palmar fibromatosis vary depending on the severity of the condition and its impact on hand function Mild cases may not require immediate treatment but should be regularly monitored However if the symptoms worsen or hinder hand function there are several treatment options available Extracorporeal shock wave therapy ESWT is a non-invasive physical therapy procedure that uses high-energy sound waves to treat various musculoskeletal conditions It is commonly used to manage pain and promote healing in conditions such as plantar fasciitis tendinitis calcific tendinitis and other similar disorders The ESWT has shown promising results in reducing pain improving function and promoting healing in various musculoskeletal conditions sixty patients with palmar fibromatosis will be assigned randomly to two groups first one will receive extracorporeal shock wave with traditional therapy and the other one will receive traditional therapy only

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None